Skip to content

Assistant diagnosis machinery system development based on speech and movement sensitive device for Parkinson's disease

Parkinson's disease, Assistant diagnosis machinery system, speech, movement sensitive device

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032616
Enrollment
Unknown
Registered
2020-05-04
Start date
2020-05-30
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Gold Standard:clinical outcome meet 2015 MDS-probable PD criteria
and&#32
analysis&#32
device,Wearable&#32

Sponsors

Shanghai Jiao Tong University School of Medicine affiliated Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male or female aged 50 years or older at time of PD diagnosisA diagnosis of Parkinson disease for 1 year or moreSubjects must have at least two of the following: resting tremor, bradykinesia, rigidity (must have either resting tremor or bradykinesia as one of two symptoms); OR either asymmetric resting tremor or asymmetric bradykinesia. Dopamine treatment effectiveModified Hoehn and Yahr stage IIV at screening, Able to give written informed consent, as determined by the investigator. Able to perform all study activities (including walking tasks and timed up and go), Willingness and ability to comply with study requirements.

Exclusion criteria

Exclusion criteria: A diagnosis of atypical parkinsonism, drug-induced parkinsonism, essential tremor, primary dystonia or other diagnoses that explain symptoms other than PD. A diagnosis of a significant CNS disease other than PD; history of repeated head injury; history of epilepsy or seizure disorder other than febrile seizures as a child that would interfere with ability to perform study assessments. History of a brain magnetic resonance imaging (MRI/CT) scan indicative of clinically significant abnormality as determined by the investigator. Concomitant disease, condition, medication, or laboratory abnormality that, in the opinion of the investigator, could interfere with study conduct or analysis, or pose an unacceptable risk to the participant. This could include neurologic, orthopedic or cardiovascular diseases. Drug abuse, excessive drinking or malnutrition. Nose, mouth or throat disease influence voice quality.

Design outcomes

Primary

MeasureTime frame
cognitive impairment;Fall risk;

Countries

China

Contacts

Public ContactLiu Ye

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,

lewys@126.com+86 13917244301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026